Thalidomide can costimulate or suppress CD4+ cells' ability to incorporate [H3]-thymidine - Dependence on the primary stimulant

International Immunopharmacology

Volumn 2, Issue 8, 2002, Pages 1143-1153

  Shannon, Edward J ^a   Sandoval, Felipe G ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

IFN ; IL 2; T cell proliferation; Thalidomide

Indexed keywords

ANTIBODY; CD3 ANTIBODY; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 2; PHYTOHEMAGGLUTININ; STAPHYLOCOCCUS ENTEROTOXIN A; THALIDOMIDE; THYMIDINE; UNCLASSIFIED DRUG; CYTOKINE; TRITIUM;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HUMAN; IMMUNOMODULATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; CD4+ T LYMPHOCYTE; IMMUNOLOGY; METABOLISM;

CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HUMAN; THALIDOMIDE; THYMIDINE; TRITIUM; HUMANS;

EID: 0035993217     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00066-8     Document Type: Article

References (22)

1. Immunomodulation by thalidomide: Systemic review of the literature and of unpublished observations
2. Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, staphylococcal enterotoxin A, and purified protein derivative
3. Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-α
4. Thalidomide prolonged graft survival in a rat cardiac transplant moded but had no inhibitory effect on lymphocyte function in vitro
5. Does thalidomide affect IL-2 response and production?
6. Immunological effects of thalidomide: Inactivity of the drug and several hydrolysis products in mononucleocyte proliferation
7. Kinetics of IL-2 and interferon-γ production expression of IL-2 receptors and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A
8. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes
9. Effect of thalidomide on apoptosis of lymphocytes and neutrophils
10. Selective down-regulation of T cell and non-T cell-derived tumor necrosis factor α by thalidomide: Comparisons with dexamethasone
11. Thalidomide and its metabolites have no effect on human lymphocyte proliferation
12. Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood
13. Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells
14. Thalidomide can be either agonistic of antagonistic to LPS evoked synthesis of TNF-α by mononuclear cells
15. Binding of staphylococcal entertoxin A to accessory cells is a requirement of its ability to activate human T-cells
16. Thalidomide costimulates primarily human T Lymphocytes, preferentially inducing proliferation, cytokine production and cytotoxic responses in the CD8+ subset
17. Thalidomide simulates T-cell responses and Interleukin 12 production in HIV-Infected patients
18. Production of IL-8 and IL-4 by positively and negatively selected CD4+ and CD8+ human T cells following a four-step cell separation method including magnetic cell sorting (MACS)
19. Thalidomide-induced-antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis
20. Study of immunological and virological parameters during thalidomide treatment of SIV-infected cynomolgus monkeys